Karl Pfleger, PhD

Karl Pfleger, PhD

Creator
0 followers

Longevity biotech investor (agingbiotech.info); shares market maps, trials, and funding views.

Understanding Broad Aging Slowdown vs Targeted Rejuvenation
SocialApr 22, 2026

Understanding Broad Aging Slowdown vs Targeted Rejuvenation

The 2 Longevity Fields... New post on a topic of great importance. Long, but something I feel strongly about. Broadly Slowing Aging vs. Divide-and-Conquer Rejuvenation: How to tell the difference and why acknowledging both matters (link in next post) https://t.co/khHlClSAWo

By Karl Pfleger, PhD
Waymo Highway Ride Smooth and Safe, Drop‑off Imprecise
SocialApr 2, 2026

Waymo Highway Ride Smooth and Safe, Drop‑off Imprecise

My first Waymo highway ride was smooth & easy. The highway part was perfect. Got dropped off a few buildings away from the actual destination address though, so still some room for improvement. But felt totally safe. https://t.co/tKXJFImzw8

By Karl Pfleger, PhD
Choosing Aging Over Longevity Highlights Pathology, Not Greed
SocialApr 1, 2026

Choosing Aging Over Longevity Highlights Pathology, Not Greed

One reason I dislike saying healthspan or lifespan & prefer aging as label for the field over longevity. Aging puts focus on its terrible consequences/pathology. It makes the field defensive like medicine not greedy as some see wanting more life...

By Karl Pfleger, PhD
US Obesity Prevalence Rises to 69% with New Metrics
SocialMar 28, 2026

US Obesity Prevalence Rises to 69% with New Metrics

Obesity (in the US) is much more common than prev thought: 69% vs. old 43% stat Based on new better definition that uses not only BMI but also anthropomorphic measures such as waist & ratios of it, which more accurately shows higher...

By Karl Pfleger, PhD
D+Q Senolytic Linked to Brain Demyelination, Prompting Safety Concerns
SocialMar 25, 2026

D+Q Senolytic Linked to Brain Demyelination, Prompting Safety Concerns

The recent study showing D+Q causes demyelination in brain cells leads to more questions than it answers: (I only read the abstract cause paper new & paywalled.) D+Q has been used a lot in mice & humans. Why hasn't this been noticed...

By Karl Pfleger, PhD
Combat Aging Now: Common Longevity Concerns Overstated
SocialMar 9, 2026

Combat Aging Now: Common Longevity Concerns Overstated

Why is it vital for humanity to fight aging? Why are common longevity worries not big problems? My new review: https://t.co/tIcXYBFE7U a preprint of a book chapter for the upcoming radical longevity book that many in the field have contributed to. https://t.co/NFTYSMALzD

By Karl Pfleger, PhD
Longevity Conference Calendar Revealed, Forum Starts Next Week
SocialMar 5, 2026

Longevity Conference Calendar Revealed, Forum Starts Next Week

2026 aging/longevity conferences mostly have announced dates now. A few date just announced. Here's what the schedule looks like at the moment. Next up is Longevity Global's Longevity Innovation Forum in San Diego next week. https://t.co/mIDmfQD38H I'll be there & speaking. https://t.co/4mRLXJmGgg

By Karl Pfleger, PhD
Introduce High Schoolers to Aging Careers Early
SocialMar 5, 2026

Introduce High Schoolers to Aging Careers Early

Is it time to start exposing high schoolers to the aging/longevity field: basic reasons it's important & a worthy potential career area? High schools have career days where adults jobs & careers. I just did a 1hr intro to aging &...

By Karl Pfleger, PhD